Tumour antigen targeted monoclonal antibodies incorporating a novel multimerisation domain significantly enhance antibody dependent cellular cytotoxicity against colon cancer

MLA

William S. Twadell, et al. “Tumour Antigen Targeted Monoclonal Antibodies Incorporating a Novel Multimerisation Domain Significantly Enhance Antibody Dependent Cellular Cytotoxicity against Colon Cancer.” European Journal of Cancer, vol. 49, Oct. 2013, pp. 3344–52. EBSCOhost, https://doi.org/10.1016/j.ejca.2013.06.009.

APA

William S. Twadell, Ling Cai, Edward So, Scott E. Strome, Xiaoyu Zhang, Dan H. Schulze, David S. Block, Bhawna Poonia, Erin Burch, Ajay N. Jain, Emmanuel Y. Mérigeon, Henrik S. Olsen, Nader Hanna, Harris G. Yfantis, Ravi Vyzasatya, & Siaw L. Chan. (2013). Tumour antigen targeted monoclonal antibodies incorporating a novel multimerisation domain significantly enhance antibody dependent cellular cytotoxicity against colon cancer. European Journal of Cancer, 49, 3344–3352. https://doi.org/10.1016/j.ejca.2013.06.009

Chicago

William S. Twadell, Ling Cai, Edward So, Scott E. Strome, Xiaoyu Zhang, Dan H. Schulze, David S. Block, et al. 2013. “Tumour Antigen Targeted Monoclonal Antibodies Incorporating a Novel Multimerisation Domain Significantly Enhance Antibody Dependent Cellular Cytotoxicity against Colon Cancer.” European Journal of Cancer 49 (October): 3344–52. doi:10.1016/j.ejca.2013.06.009.